Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 107
Selected: 0
NCT IDTitle
NCT06107738Iberdomide and Daratumumab As Maintenance Therapy After an Autologous Stem Cell Transplant for Multiple Myeloma
NCT03404635Monotherapy Anticoagulation To Expedite Home Treatment of Venous Thromboembolism
NCT06816992ORIC-114 in Combination with Subcutaneous Amivantamab in Patients with EGFR Exon20 Insertion Mutant NSCLC
NCT04394936An Explorative Psoriasis Biomarker Study
NCT01947920A Dose Ranging Escalation Study of Tramadol Hydrochloride in Healthy Volunteers
NCT02342249Study of Acute Uncomplicated Seasonal Influenza A in Adult Subjects
NCT00404989Antiretroviral Pregnancy Registry (APR): Multi-sponsor Registry to Detect Any Major Teratogenic Effect Involving Any of the Registry Drugs When Administered to Pregnant People.
NCT04407442Daratumumab, Azacitidine, and Dexamethasone for Treatment of Patients With Recurrent or Refractory Multiple Myeloma Previously Treated With Daratumumab
NCT03586570A Study to Evaluate How Aprocitentan is Safe and How it is Absorbed and Broken Down in the Body of Japanese and Caucasian Subjects
NCT05619536Study of CD388 Subcutaneous Administration in Healthy Japanese Subjects
NCT06549634Biomarkers of AKI in Patients Receiving Daratumumab
NCT03475628Effects of Daratumumab Monotherapy on Bone Parameters in Patients With Relapsed and /or Refractory Multiple Myeloma
NCT03397186Immune Changes Following Trabectedin in Patients With Metastatic or Unresectable Sarcoma
NCT05601973Amivantamab, Lazertinib and Bevacizumab in Patients With EGFR-mutant Advanced Non-small Cell Lung Cancer With Progression on Previous Third-generation EGFR-TKI
NCT017514513-arm Study of Abiraterone Acetate Alone, Abiraterone Acetate Plus Degarelix, a GnRH Antagonist, and Degarelix Alone for Patients With Prostate Cancer With a Rising PSA or a Rising PSA and Nodal Disease Following Definitive Radical Prostatectomy
NCT04162366A Research Study to Show Aprocitentan is Efficacious and Safe to Treat Patients With Uncontrolled Blood Pressure and Chronic Kidney Disease.
NCT03823924Changes in Body Composition Under Ustekinumab in PsA
NCT03290950A Study of Daratumumab in Patients With Newly Diagnosed Multiple Myeloma
NCT01376401Bendamustine, Bortezomib (Velcade ®) and Prednisone (BVP) in Patients Newly Diagnosed Multiple Myeloma
NCT00000975A Study of Itraconazole in the Treatment and Prevention of Histoplasmosis, a Fungal Infection, in Patients With AIDS
NCT04371380Pharmacokinetic Study of Cabotegravir and Rilpivirine Long-acting Intramuscular Injections in Healthy Adult Participants
NCT00002132Randomized, Controlled, Double-Blind Study of Itraconazole Oral Solution Versus Fluconazole Tablets for the Treatment of Esophageal Candidiasis.
NCT00855413HIV Viremia and Persistence in Acutely HIV-Infected Patients Treated With Darunavir/Ritonavir and Etravirine
NCT02838693Assessing Progression to Type-2 Diabetes (APT-2D): A Prospective Cohort Study Expanded From BRITE-SPOT (Bio-bank and Registry for StratIfication and Targeted intErventions in the Spectrum Of Type 2 Diabetes)
NCT02207062Ibrutinib in Treating Patients With Relapsed or Refractory Transformed Indolent B-cell Non-Hodgkin Lymphoma
NCT00215241Risperidone Augmentation for PTSD
NCT00001018A Study of Letrazuril in the Treatment of AIDS-Related Diarrhea
NCT02955810Cyclophosphamide-Bortezomib-Dexamethasone (CyBorD) With Daratumumab (DARA)
NCT04240210Integrase Regimen Switch to Symtuza to Increase Tolerability/Adherence (SYMita)
NCT01837862A Phase I Study of Mebendazole for the Treatment of Pediatric Gliomas
NCT05629052TrEatment Approach in the Multimodal Era Registry
NCT03503344Apalutamide With or Without Stereotactic Body Radiation in Treating Castration-Resistant Prostate Cancer
NCT02120352A Phase IIb Study to Evaluate a Long-Acting Intramuscular Regimen for Maintenance of Virologic Suppression (Following Induction With an Oral Regimen of GSK1265744 and Abacavir/Lamivudine) in Human Immunodeficiency Virus Type 1 (HIV-1) Infected, Antiretroviral Therapy-Naive Adult Subjects
NCT02471196Efficacy of ORM-12741 on Agitation/Aggression Symptoms in Alzheimer's Disease
NCT06066346A Study of Talquetamab for People With Multiple Myeloma Who Have Received BCMA CAR T-Cell Therapy
NCT03993847CLassification of Axial SpondyloarthritiS Inception Cohort
NCT00140426A Double-blind, Placebo Controlled Trial of Risperidone for the Treatment of Anorexia Nervosa
NCT01701063An Open-Label Study of the Effect of Telaprevir in Combination With Peginterferon Alfa-2b and Ribavirin in Pediatric Subjects Infected With Hepatitis C Virus
NCT02987829Phase 1/2A Study of TRC253, an Androgen Receptor Antagonist, in Metastatic Castration-resistant Prostate Cancer Patients
NCT02951052Study Evaluating the Efficacy, Safety, and Tolerability of Switching to Long-acting Cabotegravir Plus Long-acting Rilpivirine From Current Antiretroviral Regimen in Virologically Suppressed HIV-1-infected Adults
NCT06358638Sickle Cell Disease Transplant Using a Nonmyeloablative Approach for Patients With Anti-donor Red Cell Antibody
NCT02478632Bone Mineral Density in Human Immunodeficiency Virus Type 1 (HIV-1)-Infected Adult Subjects Switching From a Tenofovir Regimen to a Dolutegravir Plus Rilpivirine Regimen
NCT05304858Tumor Microenvironment Analysis of Prostate Cancer Metastasis
NCT02429791Regimen Switch to Dolutegravir + Rilpivirine From Current Antiretroviral Regimen in Human Immunodeficiency Virus Type 1 Infected and Virologically Suppressed Adults (SWORD-1)
NCT04089345Stelara fOr ChRonic AntibioTic rEfractory pouchitiS
NCT05109559Ad26.COV2.S as a Heterologous Booster in Adults After Single- or Two-Dose of Inactivated COVID-19 Vaccine
NCT03899155Pan Tumor Rollover Study
NCT00006371A Phase II Trial of Early Medical Adrenalectomy for "D0.5" Prostate Cancer
NCT02745054Safety of Oral Anticoagulants Registry
NCT01241760VX-950-C211 - A Dosing Regimen Study (Twice Daily Versus Every 8 Hours) of Telaprevir in Treatment-naïve Participants With Genotype 1 Chronic Hepatitis C Virus Infection